India Readies More Regulatory Reform, Globally ‘Aligned’ Biosimilars Guidance

US FDA official shares updates on voluntary QMM assessment program

 
• By Anju Ghangurde
  
India is pushing ahead with more regulatory streamlining (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pathways & Standards

More from Pink Sheet